HETEROGENEITY OF TYPE-I VONWILLEBRAND DISEASE - EVIDENCE FOR A SUBGROUP WITH AN ABNORMAL VONWILLEBRAND-FACTOR
- 1 January 1985
- journal article
- research article
- Vol. 66 (4), 796-802
Abstract
Type I von Willebrand disease (vWD) is characterized by equally low plasma concentrations of von Willebrand factor antigen (vWF:Ag) and ristocetin cofactor (RiCof) and by the presence of all vWF multimers in sodium dodecyl sulfate (SDS)-agarose gel electrophoresis. For 17 patients (13 kindreds) diagnosed with these criteria, we have studied the platelet contents of vWF:Ag and RiCof and the changes of these in plasma after DDAVP infusion. Platelet vWF:Ag and RiCof were normal in 4 kindreds (called "platelet normal" subgroup); following 1-deamino-8-D-arginine vasopressin; plasma vWF:Ag, RiCof and the bleeding time (BT) became normal. In 6 kindreds, platelet vWF:Ag and RiCof were equally low (platelet low); after DDAVP, plasma vWF:Ag and RiCof remained low, and the BT was prlonged. In 3 additional kindreds, platelets contained normal concentrations of vWF:Ag, but RiCo was very low (platelet discordant); even though a complete set of multimers was found in plasma and platelets, there was a relatively small amount of large multimers. After DDAVP, plasma vWF:Ag became normal, but RiCof remained low and the BT was very prolonged. These findings demonstrated that there can be an abnormal vWF (RiCof < vWF:Ag) even in type I vD, coexisting with a complete set of vWF multimers (platelet discordant); that the abnormal vWF can be shown more clearly in platelets than in plasma or else in plasma after DDAVP infusion; and that DDAVP normalizes the BT only in those patients with normal platelet levels of both vWF:Ag and RiCof (platelet normal).This publication has 12 references indexed in Scilit:
- MULTIMERIC COMPOSITION OF FACTOR-VIII VONWILLEBRAND-FACTOR FOLLOWING ADMINISTRATION OF DDAVP - IMPLICATIONS FOR PATHO-PHYSIOLOGY AND THERAPY OF VONWILLEBRANDS DISEASE SUBTYPES1982
- THE COMPLEX MULTIMERIC COMPOSITION OF FACTOR-VIII-VONWILLEBRAND FACTOR1981
- PRECIPITATING ANTIBODIES TO FACTOR-VIII-VONWILLEBRAND FACTOR IN VONWILLEBRANDS DISEASE - EFFECTS ON REPLACEMENT THERAPY1981
- Variant von Willebrand's DiseaseJournal of Clinical Investigation, 1980
- FACTOR-VIII-RELATED PROPERTIES IN PLATELETS FROM PATIENTS WITH VONWILLEBRANDS DISEASE1978
- Stabilization of Factor VIII in Plasma by the von Willebrand FactorJournal of Clinical Investigation, 1977
- 1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASEThe Lancet, 1977
- Immunoradiometric Assay of Factor VIII Related Antigen, with Observations in 32 Patients with von Willebrand's DiseaseBritish Journal of Haematology, 1976
- Failure of AHF concentrate to control bleeding in von Willebrand's diseaseAmerican Journal Of Medicine, 1976
- The Treatment of Haemorrhage in von Willebrand's Disease and the Blood Level of Factor VIII (AHG)British Journal of Haematology, 1963